Vice President, Business Development, Vision, Johnson & Johnson

Assaf Guterman

Assaf leads business development activities for our Vision business, including directing strategic, investment, and portfolio decisions to drive growth.

Photo of Assaf Guterman, Vision, Johnson & Johnson

Assaf has over 20 years of experience in investment banking, equity research, and corporate development within the medical device and pharmaceuticals sectors. Since joining Johnson & Johnson in 2020 as Senior Director of Business Development for Vision, he has led strategic initiatives that include licensing agreements, partnerships, asset divestitures, and equity investments, all aimed at enhancing our growth trajectory and aligning our vision with market demands.

Throughout his career, Assaf has demonstrated an ability to translate unmet customer and market needs into actionable business opportunities. His leadership has been characterized by a commitment to fostering long-term partnerships and mentoring team members to achieve shared goals.

Before joining Johnson & Johnson, Assaf held key positions at leading companies, where he drove significant changes in strategy and business planning and managed corporate finance and strategic initiatives.

Assaf holds a bachelor’s degree in political science from Tel Aviv University and a MBA in Finance from Baruch College.

Clear Vision For You
Not actual patients or healthcare professionals. For illustrative purposes only.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Johnson & Johnson Vision, Inc., its subsidiaries or affiliates.

No use of any Johnson & Johnson Vision, Inc. trademark, trade name, or trade dress in this site may be made without the prior written authorization of Johnson & Johnson Vision, Inc., except to identify the product or services of the company. Third party trademarks are the property of their respective owners.

This website and the information contained herein is intended for use by US residents only.

© Johnson & Johnson and its affiliates 2024